ABSTRACTS

A-112 ABSENCE OF PEAR1 DOES NOT AFFECT MURINE PLATELET FUNCTION

BJH - volume 8, issue Abstract Book BSTH, february 2017

M. Criel , B. Izzi , C. Vandenbriele MD, PhD, L. Liesenborghs , S. van Kerckhoven , M. Lox , K. Cludts , E. A.V. Jones , T. Vanassche MD, PhD, P. Verhamme MD, PhD, M. Hoylaerts

Read more

A-130 AMPKα1 PARTICIPATES IN THE REGULATION OF THROMBIN-INDUCED PHOSPHATIDYLSERINE EXPOSURE IN PLATELETS THROUGH ACETYL-COA CARBOXYLASE PHOSPHORYLATION

BJH - volume 8, issue Abstract Book BSTH, february 2017

S. Lepropre , S. Kautbally , L. Bertrand , V.M. Darley-Usmar , G.R. Steinberg , B.E. Kemp , C. Beauloye , C. Oury , S. Horman

Read more

O.1 Infusion of mesenchymal stem cells (MSC) as treatment for steroid refractory acute graft-versus-host study (aGVHD): a multicenter prospective phase II study of the BHS

BJH - volume 7, issue Abstract Book BHS, january 2016

S. Servais MD, PhD, D. Selleslag MD, J. Maertens MD, PhD, L. Lechanteur , E. Baudoux MD, P. Zachée MD, PhD, H. Schouten , L. Noens MD, PhD, P. Lewalle MD, PhD, W. Schroyens MD, PhD, A. Ory , Y. Beguin MD, PhD

Read more

O.2 RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response

BJH - volume 7, issue Abstract Book BHS, january 2016

I. Hofman , M. Van Duin , G. Mulligan , S. Vereecke , E. Geerdens , E. Garelli , C. Mancini , H. Lemmens , M. Delforge MD, PhD, P. Vandenberghe MD, PhD, I. Wlodarska , A. Aspesi , L. Michaux MD, PhD, P. Sonneveld , K. De Keers-maecker

Read more

O.3 IgHV Mutational Status Analysis By Next-Generation Deep Sequencing In Chronic Lymphocytic Leukemia Patients: Prognostic Significance Of Multiple Subclones And Implication For Disease Cell Origin

BJH - volume 7, issue Abstract Book BHS, january 2016

B. Stamatopoulos , A. Timbs , H. Dreau , R. Clifford , P. Robbe , A. Burns , J. Mason , A. Schuh

Read more

O.4 SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma

BJH - volume 7, issue Abstract Book BHS, january 2016

R. Heusschen PhD, J. Muller MSc, M. Binsfeld , E. Plougonven , N. Mahli , G. Carmeliet , A. Léonard , prof. F. Baron , M. Cohen-Solal , K. Vanderkerken PhD, Y. Beguin MD, PhD, E. Menu , J. Caers MD, PhD

Read more

O.5 BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: a systematic review and meta-analysis on the risk of cardiovascular events, major molecular response and overall survival

BJH - volume 7, issue Abstract Book BHS, january 2016

H. Haguet , J. Douxfils PhD, PharmD, F. Mullier PhD, PharmD, C. Chatelain MD, C. Graux MD, PhD, J-M. Dogné PhD, PharmD

Read more